-
141
Impetus of US hospital leaders to invest in patient-reported outcome measures (PROMs): a qualitative study
Published 2022-07-01Get full text
Article -
142
-
143
-
144
Single-ion gel-polymer electrolyte for improving the performances of Li-ion batteries
Published 2025-03-01Get full text
Article -
145
-
146
-
147
-
148
An optimized data analytics pipeline for improving healthcare diagnosis using ensemble learning
Published 2025-01-01Get full text
Article -
149
Toward Generality of a Framework for Quantifying Biomechanical Stability: Demonstration on the Ankle
Published 2025-01-01Get full text
Article -
150
Can Electric Vehicle Charging Stations Be Carbon Neutral With Solar Renewables?
Published 2025-01-01Get full text
Article -
151
-
152
Individual patterns of anadromy determine the cost of salmon lice exposure in brown trout
Published 2024-12-01Get full text
Article -
153
-
154
-
155
-
156
-
157
Gender differences in early posttraumatic stress disorder symptoms: a network analysis
Published 2025-12-01Get full text
Article -
158
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St...
Published 2025-01-01“…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47 416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
Get full text
Article -
159
-
160